In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Insights from ESC Congress 2025: Cardiogenic Shock and Critical Care Updates

In this  interview, three leading critical care cardiologists analyze the most impactful data and clinical trials presented at the ESC Congress 2025. 

The discussion covers pivotal studies including:

  • REBOOT Trial
  • BETAMIDAN Block
  • DANGER Shock Trial

Beyond trial data, the experts discuss the evolving role of shock centers, recent mechanical circulatory support (MCS) age analyses, and highlight what the Acute Cardiovascular Care Association (ACVC) is bringing to the field of cardiogenic shock — from research and guidelines to clinical implementation and continuous education.

 

About the ESC
Press and Media
Information
Follow us

         

 Need help?

 Help centre
 Contact us

© 2025 European Society of Cardiology. All rights reserved.